Recent Posts

SOLACI/SIAC 2021 Guideline on the use of TAVI vs SAVR in Latin America: Presentation at ICBA Grand Rounds.

Pablo Lamelas – Last Thursday June 24th the first SOLACI/SIAC joint guideline was presented at ICBA Instituto Cardiovascular Rounds. Here we present a summary in English with outstanding faculty, an … Continue reading SOLACI/SIAC 2021 Guideline on the use of TAVI vs SAVR in Latin America: Presentation at ICBA Grand Rounds.

Readdressing the validity of Repeat Revascularization outcome in PCI vs CABG trials

Pablo Lamelas – In the last decades multiple trials comparing the efficacy of PCI vs CABG incorporated repeat revascularization in the primary composite outcome, which favoured CABG repeatedly, and frequently … Continue reading Readdressing the validity of Repeat Revascularization outcome in PCI vs CABG trials

NOACs in stable CAD with Atrial Fibrillation: with or without aspirin? The AFIRE trial

Fernando Botto – A general rule dictates “the more the antithombotic effect, the higher the risk of bleeding”. In stable CAD patients beyond 1 year of PCI or without prior … Continue reading NOACs in stable CAD with Atrial Fibrillation: with or without aspirin? The AFIRE trial